Puente J, Calderero V, García-Muro X, Trigo JM, Castro AJ, Martín-Escudero V, Yébenes M, Casado MA

Costs of adverse events management associated to the treatment of first-line metastatic renal cell carcinoma with bevacizumab + interferon alpha-2a compared with sunitinib in Spain

34th Congress of the European Society for Medical Oncology (ESMO). Berlin, Germany. 20-24 sep 2009